Literature DB >> 6347577

Urinary excretion of N-acetyl-beta-D-glucosaminidase in children with type I diabetes mellitus.

E N Ellis, B H Brouhard, L Lagrone, L B Travis.   

Abstract

N-acetyl-beta-D-glucosaminidase (NAG), a lysosomal enzyme, has been shown to be increased in the urine of patients with various glomerulonephritides, tubulointerestitial diseases, renal allograft rejection, toxic renal injury, and diabetes mellitus. Although it has been suggested that urinary NAG may reflect blood glucose control, no studies have correlated this with other measures of metabolic control. Thirty-four children from a diabetic summer camp were found to have urinary NAG to creatinine ratios significantly above those of normal controls of similar age (5.22 +/- 1.19 versus 1.51 +/- 0.17 U). Urinary NAG was found to positively correlate with an arbitrary control index (r = 0.82; P less than 0.05) and in seven patients with hemoglobin A1c (r = 0.70; P less than 0.001). In a closely followed group of 40 clinic patients, urinary NAG to creatinine ratio was again found to be significantly increased over normal controls (7.55 +/- 0.70 versus 1.51 +/- 0.17 U; P less than 0.05). Again, urinary NAG was positively correlated with HbA1c (r = 0.62; P less than 0.001) and urinary albumin to creatinine ratio (r = 0.47; P less than 0.01). In neither group was there a correlation with UNAG:UCr and duration of disease. Thus, these data suggest that urinary NAG to creatinine ratio appears to be a reflection of blood sugar control.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6347577     DOI: 10.2337/diacare.6.3.251

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  6 in total

1.  Electrophoretic analysis of urinary proteins in diabetic adolescents.

Authors:  G Koliakos; F Papachristou; M Papadopoulou; V Trachana; M Gaitatzi; I Sotiriou
Journal:  J Clin Lab Anal       Date:  2001       Impact factor: 2.352

2.  Urinary N-acetyl beta glucosaminidase and gamma glutamyl transferase as early markers of diabetic nephropathy.

Authors:  Vivek Ambade; Parduman Sing; B L Somani; Dashrath Basanna
Journal:  Indian J Clin Biochem       Date:  2006-09

3.  Microheterogeneity of urinary albumin and tubular proteinuria in juvenile diabetes mellitus.

Authors:  M Ries; K Schärer; R Wartha; H Schmidt; D Gekle
Journal:  Pediatr Nephrol       Date:  1991-09       Impact factor: 3.714

4.  Urinary N-acetyl-β-D-glucosaminidase levels are positively correlated with 2-hr plasma glucose levels during oral glucose tolerance testing in prediabetes.

Authors:  Motoshi Ouchi; Tatsuya Suzuki; Masao Hashimoto; Masayuki Motoyama; Makoto Ohara; Kazunari Suzuki; Yoshimasa Igari; Kentaro Watanabe; Hiroshi Nakano; Kenzo Oba
Journal:  J Clin Lab Anal       Date:  2012-11       Impact factor: 2.352

5.  Uric acid lowering in relation to HbA1c reductions with the SGLT2 inhibitor tofogliflozin.

Authors:  Motoshi Ouchi; Kenzo Oba; Kohei Kaku; Hideki Suganami; Akihiro Yoshida; Yasunori Fukunaka; Promsuk Jutabha; Asuka Morita; Naoyuki Otani; Keitaro Hayashi; Tomoe Fujita; Tatsuya Suzuki; Masahiro Yasutake; Naohiko Anzai
Journal:  Diabetes Obes Metab       Date:  2018-01-08       Impact factor: 6.577

6.  Impact of blood glucose levels on the accuracy of urinary N-acety-β-D-glucosaminidase for acute kidney injury detection in critically ill adults: a multicenter, prospective, observational study.

Authors:  Lin Wang; Yujun Deng; Yiling Zhai; Feng Xu; Jinghua Li; Danqing Zhang; Lu Gao; Yating Hou; Xin OuYang; Linhui Hu; Jie Yuan; Heng Ye; Ruibin Chi; Chunbo Chen
Journal:  BMC Nephrol       Date:  2019-05-24       Impact factor: 2.388

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.